课题基金 / 基金详情

The role of Notch in establishing ovarian interstitial cells

The role of Notch in establishing ovarian interstitial cells
Notch在建立卵巢间质细胞中的作用
批准号:
10273760
负责人:
Saniya Rattan
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2024-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Ovarian dysfunction is one of the leading causes behind women experiencing infertility in the United States. Ovarian diseases and dysfunctions such as polycystic ovarian syndrome, androgen-producing tumors, primary ovarian insufficiency, or hyperandrogenism contribute to infertility in women. Often these diseases result from defects in ovary formation, particularly during fetal life. Formation of the fetal ovary requires the presence of three main cell lineages: the germ cell lineage forms oocytes, the supporting cell lineage becomes granulosa cells, and the interstitial cell lineage contribute to steroidogenic and non-steroidogenic stromal cell populations. Germ cell and supporting cell lineages in the ovary are studied extensively due to the fact that these two cell types form the follicles, the functional unit in the ovary. On the contrary, the interstitial cell lineage is less studied despite that its dysfunction is associated with ovarian diseases. A critical knowledge gap on ovarian interstitial cells is the cellular dynamics necessary for its specification and formation. The main goal of this application is to fill this knowledge gap and lay the foundation for advances in disease diagnosis, treatment, and prevention by using the mouse as the model. Within the applicant’s first year as a post-doctoral fellow in the Yao Laboratory, they discovered a unique population of cells in the ovary that activate Notch and specifically develop into interstitial cells in adulthood indicating that Notch may play a role in ovarian cell development. These findings lead to the central hypothesis of this proposal: Notch activation establishes the interstitial cell lineage in the fetal ovary. AIM 1 will investigate whether ovarian interstitial cell development requires Notch activation. This will be accomplished by using a conditional and inducible genetic mouse model that silences Notch activation in the progenitor interstitial cell population. AIM 2 will test whether ectopic Notch activation will transform the supporting cells into interstitial cells through the use of separate, conditional, and inducible genetic mouse model that specifically targets the supporting cell population. Ovaries from all of the genetic mouse models will be dissected, morphologically analyzed, and subjected to single cell RNA sequencing for analysis. AIM 3 will investigate how supporting cell and interstitial cell populations interact via the Notch pathway to define their unique identity. This will be accomplished by performing single cell sequencing on lineage traced ovaries. This proposal will address the involvement of the Notch activation in interstitial cell fate determination. Knowledge gained from this proposal will provide a better understanding of how embryonic cells gain their progenitor identity and the mechanisms driving ovarian interstitial cell development. With this information, future studies can directly address the impacts of the environment or other stressors on these processes. Finally, these results may be translated to human health risks involving ovarian disease and dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于 ANKRD22 介导的脂代谢重编程激活Notch4/HES1 通路促进巨噬细胞获得免疫抑制表型机制研究
  • 批准号:
    ZCLMS26H1601
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖于飞
  • 依托单位:
电针调控 Notch 信号通路促进脑缺血再灌注损伤神经血管单元调节和保护作用
  • 批准号:
    2026JJ82306
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    袁高明
  • 依托单位:
超级增强子NFIX-SE募集MEF2C激活NFIX/NOTCH通路增强肿瘤细胞干性导致小细胞肺癌化疗耐药的机制研究
  • 批准号:
    2026JJ81772
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    童琴
  • 依托单位:
MPE细胞团中α-SMA+肿瘤细胞激活Notch 通路促恶性进展的作用机制研究
  • 批准号:
    JCZRQNB202600536
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: